Mac Gabhann Feilim, Popel Aleksander S
Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Biophys Chem. 2007 Jul;128(2-3):125-39. doi: 10.1016/j.bpc.2007.03.010. Epub 2007 Mar 24.
Vascular endothelial growth factor (VEGF) is a potent cytokine involved in the induction of neovascularization. Secreted as a cysteine-linked dimer, it has two binding sites at opposite poles through which it may bind VEGF receptors (VEGFRs), receptor tyrosine kinases found on the surface of endothelial and other cells. The binding of a VEGF molecule to two VEGFR molecules induces transphosphorylation of the intracellular domains of the receptors, leading to signal transduction. The dominant mechanism of receptor dimerization is not clear: the receptors may be present in an inactive pre-dimerized form, VEGF binding first to one of the receptors, the second receptor then ideally located for dimerization; or VEGF may bind receptor monomers on the cell surface, which then diffuse and bind to available unligated receptor monomers to complete the activation. Both processes take place and one or other may dominate on different cell types. We demonstrate the impact of dimerization mechanism on the binding of VEGF to the cell surface and on the formation of active signaling receptor complexes. We describe two methods to determine which process dominates, based on binding and phosphorylation assays. The presence of two VEGF receptor populations, VEGFR1 and VEGFR2, can result in receptor heterodimer formation. Our simulations predict that heterodimers will comprise 10-50% of the active, signaling VEGF receptor complexes, and that heterodimers will form at the expense of homodimers of VEGFR1 when VEGFR2 populations are larger. These results have significant implications for VEGF signal transduction and interpretation of experimental studies. These results may be applicable to other ligand-receptor pairs, in particular PDGF.
血管内皮生长因子(VEGF)是一种参与诱导新血管形成的强效细胞因子。它以半胱氨酸连接的二聚体形式分泌,在相对的两极有两个结合位点,通过这些位点它可以结合VEGF受体(VEGFRs),VEGFRs是在内皮细胞和其他细胞表面发现的受体酪氨酸激酶。一个VEGF分子与两个VEGFR分子的结合会诱导受体胞内结构域的反式磷酸化,从而导致信号转导。受体二聚化的主要机制尚不清楚:受体可能以无活性的预二聚体形式存在,VEGF首先与其中一个受体结合,然后第二个受体处于理想的二聚化位置;或者VEGF可能与细胞表面的受体单体结合,然后这些单体扩散并与可用的未结合配体的受体单体结合以完成激活。这两个过程都会发生,并且在不同的细胞类型中可能其中一个占主导。我们证明了二聚化机制对VEGF与细胞表面结合以及活性信号受体复合物形成的影响。我们描述了两种基于结合和磷酸化测定来确定哪个过程占主导的方法。两种VEGF受体群体VEGFR1和VEGFR2的存在会导致受体异二聚体的形成。我们的模拟预测,异二聚体将占活性信号VEGF受体复合物的10 - 50%,并且当VEGFR2群体较大时,异二聚体将以牺牲VEGFR1的同二聚体为代价形成。这些结果对VEGF信号转导和实验研究的解释具有重要意义。这些结果可能适用于其他配体 - 受体对,特别是血小板衍生生长因子(PDGF)。